Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Current evidence on the discontinuation of eculizumab in patients with atypical haemolytic uraemic syndrome.

Macia M, de Alvaro Moreno F, Dutt T, Fehrman I, Hadaya K, Gasteyger C, Heyne N.

Clin Kidney J. 2017 Jun;10(3):310-319. doi: 10.1093/ckj/sfw115. Epub 2016 Dec 22.

2.

Adjustment of Eculizumab Dosage Pattern in Patients with Atypical Hemolytic Uremic Syndrome with Suboptimal Response to Standard Treatment Pattern.

García Monteavaro C, Peralta Roselló C, Quiroga B, Baltar Martín JM, Castillo Eraso L, de Álvaro Moreno F, Martínez Vea A, Visus-Fernández de Manzanos MT.

Case Rep Nephrol. 2016;2016:7471082. doi: 10.1155/2016/7471082. Epub 2016 Nov 29.

3.

Statement of the Spanish Interdisciplinary Cardiovascular Prevention Committee (CEIPC for its Spanish acronym) on the 2012 European Cardiovascular Prevention Guidelines.

Royo-Bordonada MA, Lobos Bejarano JM, Villar Alvarez F, Sans S, Pérez A, Pedro-Botet J, Moreno Carriles RM, Maiques A, Lizcano Á, Lizarbe V, Gil Núñez A, Fornés Ubeda F, Elosua R, de Santiago Nocito A, de Pablo Zarzosa C, de Álvaro Moreno F, Cortés O, Cordero A, Camafort Babkowski M, Brotons Cuixart C, Armario P; Spanish Interdisciplinary Cardiovascular Prevention Committee (CEIPC).

Neurologia. 2016 Apr;31(3):195-207. doi: 10.1016/j.nrl.2013.04.011. Epub 2013 Aug 20. English, Spanish.

4.

[Statement of the Spanish Interdisciplinary Cardiovascular Prevention Committee (CEIPC) on the 2012 European Cardiovascular Prevention Guidelines].

Royo-Bordonada MÁ, Lobos Bejarano JM, Villar Alvarez F, Sans S, Pérez A, Pedro-Botet J, Moreno Carriles RM, Maiques A, Lizcano A, Lizarbe V, Gil Núñez A, Fornés Ubeda F, Elosua R, de Santiago Nocito A, de Pablo Zarzosa C, de Álvaro Moreno F, Cortés O, Cordero A, Camafort Babkowski M, Brotons Cuixart C, Armario P; Comité Español Interdisciplinario para la Prevención Cardiovascular (CEIPC).

Rev Esp Salud Publica. 2013 Mar-Apr;87(2):103-20. doi: 10.4321/S1135-57272013000200002. Spanish.

5.

[Statement of the Spanish Interdisciplinary Cardiovascular Prevention Committee (CEIPC for its Spanish acronym) on the 2012 European Cardiovascular Prevention Guidelines].

Royo-Bordonada MA, Lobos Bejarano JM, Villar Alvarez F, Sans S, Pérez A, Pedro-Botet J, Moreno Carriles RM, Maiques A, Lizcano A, Lizarbe V, Gil Núñez A, Fornés Ubeda F, Elosua R, de Santiago Nocito A, de Pablo Zarzosa C, de Álvaro Moreno F, Cortés O, Cordero A, Camafort Babkowski M, Brotons Cuixart C, Armario P; en nombre del Comité Español Interdisciplinario para la Prevención Cardiovascular (CEIPC).

Clin Investig Arterioscler. 2013 Jul-Aug;25(3):127-39. doi: 10.1016/j.arteri.2013.03.003. Epub 2013 May 31. Spanish.

PMID:
23726872
6.

Implementation of Spanish adaptation of the European guidelines on cardiovascular disease prevention in primary care.

Brotons C, Lobos JM, Royo-Bordonada MÁ, Maiques A, de Santiago A, Castellanos Á, Diaz S, Obaya JC, Pedro-Botet J, Moral I, Lizarbe V, Moreno R, Pérez A, Cordero A, Fornés-Ubeda F, Serrano-Saiz B, Camafort-Babkowski M, Elosua R, Sans S, de Pablo C, Gil-Nuñez A, de Álvaro-Moreno F, Armario P, Rico OC, Villar F, Lizcano Á.

BMC Fam Pract. 2013 Mar 18;14:36. doi: 10.1186/1471-2296-14-36.

7.

[Consensus for hospital discharge reports in medical specialities].

Conthe Gutiérrez P, García Alegría J, Pujol Farriols R, Alfageme Michavilla I, Artola Menéndez S, Barba Martín R, Cañones Garzón PJ, Casado Pérez P, de Alvaro Moreno F, Escosa Royo L, Jovell Fernández A, León Gil C, Lisbona Gil A, Márquez Vázquez R, Pastor Rodríguez-Moñino A, Pérez Martínez DA.

Med Clin (Barc). 2010 Apr 17;134(11):505-10. doi: 10.1016/j.medcli.2009.12.002. Epub 2010 Feb 26. Spanish. No abstract available.

PMID:
20189203
8.

[Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].

Cases Amenós A, Goicoechea Diezhandiño M, de Alvaro Moreno F.

Nefrologia. 2008;28 Suppl 3:39-48. Spanish.

9.

Perceived mental health at the start of dialysis as a predictor of morbidity and mortality in patients with end-stage renal disease (CALVIDIA Study).

López Revuelta K, García López FJ, de Alvaro Moreno F, Alonso J.

Nephrol Dial Transplant. 2004 Sep;19(9):2347-53. Epub 2004 Jul 13.

PMID:
15252167

Supplemental Content

Loading ...
Support Center